HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING VIDEO EDUCATION SERVICES
Earnings    EPS Surprises    Mutual Funds    Options            My Account    Help    
Quote:
Login Free Membership
Search:

Top Zacks Features
Free Membership
Premium Home
Zacks Rank
Real Time Insight
Equity Research
My Portfolio
Stock Screener
Premium Screens
ETFs
Mutual Funds
Options
RSS Feed
Profit from the Pros
Subscription Services
Product Guide
Zacks Premium
Method for Trading
Chart Patterns Trader
Home Run Investor
Insider Trader
Options Trader
Reitmeister Trader
Reitmeister Value
Tactical Trader
Top 10 Stocks
Turnaround Trader
Whisper Trader
Research Wizard
Zacks Ultimate



Zacks Premium
Get profitable stock
picks and timely
market advice in
Zacks.com`s Free
Daily Newsletter!

Free Registration

View the Archive


MCK: MCKESSON CORP - Stock Quote Enter Ticker:
 

QuoteEstimatesCharts Company ReportsNewsFinancials
  Quote |  Detailed Quotes |  Real Time |  Options Chain |  Greeks Montage

MCKESSON CORP (NYSE)
MCK 82.84 N/A (N/A%) Vol.  616 N/A ET

Zacks Rank: 3 - Hold

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.
Zacks Rank Definition Annualized Return
# 1Strong Buy26.83%
# 2Buy18.69%
# 3Hold9.7%
# 4Sell4.03%
# 5Strong Sell1.63%
S&P5009.43%
Zacks Rank Education - Learn more about the Zacks Rank
Zacks Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank


Day Low - High N/A - N/A
52wk Low - High 66.61 - 87.32
Avg Volume 2,306,711
Industry RETAIL-DRUG STR
Market Cap 20.34 B
Div - Yield 0.80 - 0.97
PE (forward) 13.03
PEG Ratio .91
Current Year Est. 6.36
EPS Last Year 5.96
Detailed Quote


Premium Research: Stock Analysis

Zacks Rank

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.
Zacks Rank Definition Annualized Return
# 1Strong Buy26.83%
# 2Buy18.69%
# 3Hold9.7%
# 4Sell4.03%
# 5Strong Sell1.63%
S&P5009.43%
Zacks Rank Education - Learn more about the Zacks Rank
Zacks Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank


Short-Term Rating 1-3 Months
Zacks #1 Rank Strong Buys Zacks Premium
3 - Hold
Zacks Recommendation

Zacks Recommendations are an excellent predictor of stock price movement over a 6+ month time frame. The recommendations come from the Zacks Equity Research group which combines the Zacks Rank with the insights from their team of over 50 equity analysts. The result is superior long term stock ratings.

The Zacks Recommendations are split into 3 groups: Outperform, Neutral and Underperform. When Zacks Premium members click on the recommendation it will launch them to the Zacks Equity Research report for the stock. More on these reports below.

Difference Between Zacks Rank and Zacks Recommendation
Zacks Equity Research Home
Zacks Premium - The only way to get access to Zacks Recommendations


Long-Term Rating 6+ Months
All Outperform Rated Stocks Zacks Premium
PREMIUM
Zacks Industry Rank

Which industries are set to outperform or underperform the market? You'll find the answer here. We have broken down all industries into over 200 classifications. Then ranked these industries using the most powerful indicator we know (the Zacks Rank). The higher the industry rank, the better the industry should perform in the future. Once you have found an attractive industry then check out the Rank in Industry to find the best stocks within the industry.

When Zacks Premium members click on the Zacks Industry Rank link they will see the full listing of industries and their current rankings.

About Zacks Industry Rank
Zacks Industry Rank - All current industry ranks.
Zacks Premium - The only way to get access to the Zacks Industry Rank

PREMIUM
Target Price

The Zacks Price Target provides you our expectation for a stocks share price in the next 6 months. These price targets are created by the Zacks Equity Research group to coincide with their recommendations that are also based on a 6 month time horizon.

Zacks Equity Research Home
Zacks Premium - The only way to get access to the Zacks Price Targets

PREMIUM
Equity Research Report

The Zacks Recommendations and Zacks Target Prices are just two of the valuable resources you'll find in the reports created by the Zacks Equity Research group. When Zacks Premium members click on this link they will taken to a page that gives them access to the Zacks Equity Research report for the stock.

Zacks Equity Research Home Zacks Premium - The only way to get access to Zacks Recommendations


Updated as of 02/01/2012
PREMIUM
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium

Premium Research: Industry Analysis

Top Peers Ticker Zacks Rank
MCKESSON CORP MCK 3
CVS CAREMARK CP CVS 2
BIOSCRIP INC BIOS 3
AMERISOURCEBRGN ABC 3
Top Peer Analysis Zacks Premium
See all RETAIL-DRUG STR Peers

BROKERAGE RECOMMENDATIONS
Current ABR 1.44
ABR (Last Week) 1.53
# of Recs in ABR 16
Average Target Price 95.04
Rank in Industry 7 out of 11
More Brokerage Recommendations

Zacks Community PeopleAndPicks.com
Community Rating

PeopleAndPicks.com Community Stock Ratings

Rating Recommendation % of Stocks
5 stars Strong Buy 10%
4 stars Buy 20%
3 stars Hold 40%
2 stars Sell 20%
1 stars Strong Sell 10%
0 stars Not Rated  

We believe that a community of investors working together can create a superior stock rating system. Some call this "collective intelligence". Or simply...together we can beat the market!

A stock's Community Rating is calculated based on the aggregate input of the PeopleAndPicks Community. The proportion of buy to sell ratings, recency of analysis, and the average score of the users who rate it favorably all factor into a score of one to five stars.


How do you rate MCK?
Buy
Sell
Find out what the Zacks Community
thinks of MCK at PeopleAndPicks.com

NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.

 Interactive Java Charting
 NEW!   Fundamental Charts




 
ZACKS COMMENTARY FOR MCK
Zacks Blog: Cardinal 2Q Tops, Profit Rises
Feb 02, 2012
Zacks Equity Research: Report for MCK
Feb 01, 2012
Zacks Blog: McKesson Grows Steadily
Jan 31, 2012
Zacks Blog: Earnings Preview: Cardinal Health
Jan 30, 2012
Zacks Blog: Omnicell Posts a Strong Quarter
Jan 30, 2012
Zacks Blog: McCormick Beats, Provides Outlook
Jan 26, 2012
Zacks Blog: AmerisourceBergen Posts EPS In Line
Jan 26, 2012
Zacks Blog: Omnicell's G4 Reaches Middle East
Jan 25, 2012
More Zacks Commentary
NEWS
McKesson (MCK) Showing Bullish Technicals With Support At $82.29 - Story Title - Comtex
Feb 09, 2012
McKesson Acquires peerVue (MCK) - Story Title - Comtex
Feb 08, 2012
Top 3 Companies in the Health Care Distributors Industry With the Highest Revenue Per Employee (ABC, CAH, MCK) - Story Title - Comtex
Feb 08, 2012
Edward Owens` Vanguard Health Care Fund Beats Benchmark, Commentary on UNH, MCK, OSIP, GENZ, ... - GuruFocus
Feb 06, 2012
Further Upside Seen For McKesson (MCK, CVS, RAD, HMA, UHS) - Investopedia
Feb 06, 2012
McKesson to Present at the UBS Annual Global Healthcare Services Conference - Story Title - Comtex
Feb 05, 2012
McKesson to Speak at the UBS 22nd Annual Global Healthcare Services Conference - Story Title - Comtex
Feb 05, 2012
McKesson (MCK) Could Break Through $83.26 Resistance Level - Story Title - Comtex
Feb 03, 2012
More News
EARNINGS ESTIMATES
  This Quarter
03/2012
Next Quarter
06/2012
This Year
03/2012
Next Year
03/2013
Average Estimate 2.05 1.48 6.36 7.12
Number of Estimates 14 10 16 16
Low Estimates 2.00 1.36 6.30 6.98
High Estimate 2.10 1.68 6.48 7.35
Year Ago EPS 1.66 1.27 4.90 6.36
EPS Growth 23.67% 16.69% 29.71% 11.97%

More Estimates

COMPANY DESCRIPTION
McKesson Corporation, the world's largest health care service and technology company, delivers unique supply and information management solutions that reduce costs and improve quality for its health care customers. The Company is organized under two operating segments: Health Care Supply Management and Health Care Information Technology.

Full Company Report
FINANCIALS
EPS TTM 5.96
Sales 112084
Net Income 1304
Price/Earnings 13.9
Price/Book 2.73
Price/Cash Flow 11.8
Price/Sales .17


More Financials

 
About Zacks | Advertise | Affiliate | Media | Careers | Contact Us | Help
Disclaimer | Privacy Policy | Sitemap
NYSE and AMEX data is at least 20 minutes delayed.  NASDAQ data is at least 15 minutes delayed.
Copyright 2012 Zacks Investment Research